关注
Ann S. Kim
Ann S. Kim
Johns Hopkins
在 case.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Increased incidence of venous thromboembolism with cancer immunotherapy
J Roopkumar, S Swaidani, AS Kim, B Thapa, L Gervaso, BP Hobbs, ...
Med 2 (4), 423-434. e3, 2021
1002021
Mechanisms and biomarkers of cancer-associated thrombosis
AS Kim, AA Khorana, KR McCrae
Translational Research 225, 33-53, 2020
892020
Targeting glutamine metabolism rescues mice from late-stage cerebral malaria
EB Gordon, GT Hart, TM Tran, M Waisberg, M Akkaya, AS Kim, ...
Proceedings of the National Academy of Sciences 112 (42), 13075-13080, 2015
872015
Toll-like receptor 9 antagonizes antibody affinity maturation
M Akkaya, B Akkaya, AS Kim, P Miozzo, H Sohn, M Pena, AS Roesler, ...
Nature immunology 19 (3), 255-266, 2018
772018
Venous thromboembolism in cancer patients receiving immunotherapy
J Roopkumar, AS Kim, T Bicky, BP Hobbs, AA Khorana
Blood, The Journal of the American Society of Hematology 132 (Supplement 1 …, 2018
312018
Incidence and clinical pattern of immune related adverse effects (irAE) due to immune checkpoint inhibitors (ICI).
B Thapa, J Roopkumar, AS Kim, L Gervaso, PD Patil, C Calabrese, ...
Journal of Clinical Oncology 37 (15_suppl), e14151-e14151, 2019
302019
B cells produce type 1 IFNs in response to the TLR9 agonist CpG-A conjugated to cationic lipids
M Akkaya, B Akkaya, P Miozzo, M Rawat, M Pena, PW Sheehan, AS Kim, ...
The Journal of Immunology 199 (3), 931-940, 2017
292017
SARS-CoV-2 vaccination and immune thrombotic thrombocytopenic purpura
H Shah, A Kim, S Sukumar, M Mazepa, R Kohli, EM Braunstein, ...
Blood, The Journal of the American Society of Hematology 139 (16), 2570-2573, 2022
192022
Identifying miRNA biomarkers and predicted targets associated with venous thromboembolism in colorectal cancer patients
AS Kim, MF Kalady, J DeVecchio, K Tanriverdi, JE Freedman, J Barnard, ...
Blood 134, 3643, 2019
92019
Toll-like receptor 9 signaling antagonizes B cell antigen capture, processing and presentation resulting in a failure to activate helper T cells
M Akkaya, B Akkaya, AS Kim, P Miozzo, H Sohn, M Pena, AS Roesler, ...
The Journal of Immunology 200 (1_Supplement), 107.1-107.1, 2018
2018
DOES RADIATION EXPOSURE PORTEND WORSE POSTOPERATIVE OUTCOMES AFTER CYSTECTOMY WITH URINARY DIVERSION FOR BENIGN INDICATIONS?: MP49-11
P Babbar, A Sun, A Kim, D Hettel, S Agrawal, A Crane, D Sun, R Berglund, ...
Journal of Urology 199 (4), e670, 2018
2018
Toll-like receptor 9 signaling antagonizes antigen-specific B cell-helper T cell interactions
M Akkaya, B Akkaya, AS Kim, P Miozzo, H Sohn, M Pena, J Skinner, ...
The Journal of Immunology 198 (1_Supplement), 152.3-152.3, 2017
2017
The Toll-like receptor ligand CpG-A induces type 1 interferons in B cells contrasting the proinflammatory inducing activity of CpG-B
M Akkaya, B Akkaya, P Sheehan, P Miozzo, M Rawat, M Pena, AS Kim, ...
The Journal of Immunology 198 (1_Supplement), 152.4-152.4, 2017
2017
Closure of Mohs Micrographic Surgery Lower Extremity Wounds: Are We Wasting our Time?
S Condon, J Adegboye, A Kim, A Vij
American College of Mohs Surgery Annual Meeting, 2017
2017
Toll-like receptor 9 signaling antagonizes the B cell receptor-dependent ability of B cells to process and present antigen to helper T cells.
M Akkaya, AS Kim, P Miozzo, HW Sohn, B Akkaya, M Pena, SK Pierce
The Journal of Immunology 196 (1_Supplement), 198.6-198.6, 2016
2016
B cells have bifurcated Toll-like receptor signaling allowing both inflammatory cytokine and type 1 interferon responses.
M Akkaya, M Rawat, B Akkaya, A Chaturvedi, M Pena, P Miozzo, AS Kim, ...
The Journal of Immunology 196 (1_Supplement), 189.18-189.18, 2016
2016
Antigen- and CpG-induced B Cell early signaling events show little synergy
AS Kim, M Akkaya, HW Sohn, SK Pierce
The Golden Anniversary of B Cell Discovery (X6), 2015
2015
Novel Adjunctive Therapies for Cerebral Malaria That Target Metabolism
TM Tran, EB Gordon, GT Hart, M Waisberg, M Akkaya, A Kim, ...
Open Forum Infectious Diseases 2 (suppl_1), 1606, 2015
2015
系统目前无法执行此操作,请稍后再试。
文章 1–18